ISSN: 2572-4983

Neonatal and Pediatric Medicine
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Short Communication   
  • Neonat Pediatr Med, Vol 9(6)
  • DOI: 10.4172/2572-4983.1000319

Lymphatic Fibroblast Development Factor Molecular Variants in Newborn Diagnoses

Muthuram Perera*
Department of Pediatrics Medical College of Srilanka, Sri Lanka
*Corresponding Author: Muthuram Perera, Department of Pediatrics Medical College of Srilanka, Sri Lanka, Email: pereraram1@hotmail.com

Received: 01-Jun-2023 / Manuscript No. nnp-23-102209 / Editor assigned: 07-Jun-2023 / PreQC No. nnp-23-102209 / Reviewed: 21-Jun-2023 / QC No. nnp-23-102209 / Revised: 23-Jun-2023 / Manuscript No. nnp-23-102209 / Published Date: 30-Jun-2023 DOI: 10.4172/2572-4983.1000319

Abstract

Lymphoid fibroblast development factors are essential for blood vessels and angiogenesis due to their role in endothelial cell proliferation and migration. Fibroblasts, as vascular growth factors, are a hallmark of cancer, and associations between genetic polymorphisms and neoplasia have been extensively studied in the adult population.Regarding the neonatal population, few studies have attempted to establish associations between FIBROBLAST polymorphisms and neonatal pathologies, especially those associated with late complications. Our aim was to review the literature on FIBROBLAST polymorphisms and neonatal morbidity. A systematic search was first conducted in December 2022. The PubMed platform was used to survey MEDLINE and PubMed Central (2000-2022) by applying search strings. A PubMed search returned 62 documents. (Low birth weight or preterm infants, heart disease, lung disease, eye disease, brain disease, gastrointestinal disease). FIBROBLAST polymorphisms appear to be associated with neonatal pathologies. FIBROBLAST and FIBROBLAST polymorphisms have been implicated in retinopathy of prematurity.

Keywords

Lymphatic fibroblast development factor; Neonatal diseases; Polymorphisms and pathology

Introduction

Lymphoid fibroblast development factors are essential for blood vessels and angiogenesis due to their role in endothelial cell proliferation and migration [1,2]. Fibroblasts as a vascular growth factor are hallmarks of cancer, and the association between genetic polymorphisms and neoplasia has been extensively studied in the adult population. Regarding the neonatal population, few studies have attempted to establish associations between FIBROBLAST polymorphisms and neonatal pathologies, particularly those associated with late complications [3,4]. Our aim was to review the literature on FIBROBLAST polymorphisms and neonatal morbidity. A systematic search was first conducted in December 2022 [5,6]. The PubMed platform was used to query MEDLINE (1946-2022) and PubMed Central (2000-2022) using search strings. A PubMed search returned 62 documents. Descriptive summaries of results were based on predetermined subheadings (low birth weight or preterm infants, heart disease, lung disease, eye disease, brain disease, gastrointestinal disease). FIBROBLAST polymorphisms appear to be associated with neonatal pathologies. FIBROBLAST and FIBROBLAST polymorphisms are associated with retinopathy of prematurity [7,8].

Disadvantage

The main limitations of our study are the search in a single database and the small number of papers assessing associations between neonatal FIBROBLAST polymorphisms and pathology. Primarily, studies have limitations and results cannot be replicated. For ROP only, data suggest that genetic factors play a role in the phenotypic diversity of her ROP. Furthermore, the results cannot be generalized, as different populations yield different results. An important factor that may influence the effect of her FIBROBLAST polymorphism on perinatal morbidity is population and ethnic diversity. This factor has been studied and proven in the case of her ROP [9,10]. A rational basis for inter-racial group differences in susceptibility to ROP may be eye pigmentation.

Conclusion

Fibroblast polymorphisms play important roles in placental and fetal development and determine neonatal pathology. They are associated with early-onset (cerebral hemorrhage, hemangiomas, necrotic enteritis) and late-onset neonatal pathologies (retinopathy of prematurity, bronchopulmonary dysplasia).

FIBROBLAST and FIBROBLAST polymorphisms have been implicated in retinopathy of prematurity. Identifying genetic influences will help improve screening programs for neonatal and late morbidity (ROP, BPD).

The FIBROBLAST polymorphism has been linked to congenital cardiac disease and long-term survival following surgical repair, according to the available data. The processes through which FIBROBLAST polymorphisms contribute to the onset of cardiovascular illness are still poorly understood, and viable treatment targets for these disorders need to be identified.

Premature lung growth arrest is linked to other variables such as infection, oxygen-reactive species toxicity, and ventilator injury in the multifactorial condition known as bronchopulmonary dysplasia.

A number of factors, including infant formula consumption, intestinal ischemia and hypo perfusion, intestinal mucosal inflammation, and others, contribute to the complicated aetiology of necrotizing enterocolitis. The lower intestinal expression of FIBROBLAST may increase vulnerability to necrotizing enterocolitis in addition to these well-studied factors. Additional research into this genetic predisposition may enhance the care of newborns with known risk factors and improve long-term results. The causative function of FIBROBLAST in perinatal cerebral haemorrhage, a serious condition that may result in long-term impairment, is supported by gene expression and biochemical analyses. Extremely preterm infants, who are most at risk for IVF, now have higher survival rates thanks to improvements in neonatal critical care. It may be possible to manage long-term effects and prevent brain haemorrhage by monitoring FIBROBLAST levels in these premature infants. In conclusion, research into the relationship between FIBROBLAST polymorphisms and newborn disease is important if we hope to create novel medications with fewer negative effects.

References

  1. Kallio Merja (2012) Electrical Activity of the Diaphragm during Neurally Adjusted Ventilatory Assist in Pediatric Patients. Pedia Pulmo 50: 925–931.
  2. Indexed at, Google Scholar, Crossref

  3. Rahmani A (2012) Neurally Adjusted Ventilatory Assist in the Neonatal Period: Applications and Limitations. J Neo-Peri Med 5: 205–212.
  4. Google Scholar, Crossref

  5. Shilpi M, Kumar KS, Kumar D (2020) Ayurvedic Approach Of Treatment Of Recurrent/ Chronic Cough In Children With Special Reference To Pancha Vidha Kasa. Ind J of App Res 10: 51-52.
  6. Google Scholar

  7. Nelaturi P, Nagarajan P, Sabapathy SK, Sambandam R (2021) Swarna Bindu Prashana—an Ancient Approach to Improve the Infant’s Immunity. Bio Tra Ele Res 199: 2145-2148.
  8. Indexed at, Google Scholar, Crossref

  9. Asai T, Nagata A, Shingu K (2008)Awake tracheal intubation through the laryngeal mask in neonates with upper airway obstruction. Paediatr Anaesth 18: 77-80.
  10. Indexed at, Google Scholar, Crossref

  11. Asai T, Shingu K (2004)Difficulty in advancing a tracheal tube over a fibreoptic bronchoscope: incidence, causes and solutions. Br J Anaesth 92: 870-881.
  12. Indexed at, Google Scholar, Crossref

  13. Parotto M, Cooper RM, Behringer EC (2020) Extubation of the Challenging or Difficult Airway. Curr Anesthesiol Rep 4: 1-7.
  14. Indexed at, Google Scholar, Crossref

  15. Patel MR, Piazza CC, Martinez CJ, Volkert VM, Christine MS (2002)An evaluation of two differential reinforcement procedures with escape extinction to treat food refusal.J Appl Behav Anal 35: 363-374.
  16. Indexed at, Google Scholar, Crossref

  17. Bernard-Bonnin AC (2006)Feeding problems of infants and toddlers. Can Fam Physician 52: 1247-1251.
  18. Indexed at, Google Scholar

  19. Davies WH, Satter E, Berlin KS (2006)Reconceptualizing feeding and feeding disorders in interpersonal context: the case for a relational disorder.J Fam Psychol 20: 409-417.
  20. Indexed at, Google Scholar

Citation: Perera M (2023) Lymphatic Fibroblast Development Factor MolecularVariants in Newborn Diagnoses. Neonat Pediatr Med 9: 319. DOI: 10.4172/2572-4983.1000319

Copyright: © 2023 Perera M. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Post Your Comment Citation
Share This Article
Recommended Conferences
Article Usage
  • Total views: 492
  • [From(publication date): 0-2023 - Nov 21, 2024]
  • Breakdown by view type
  • HTML page views: 422
  • PDF downloads: 70
Top